全文获取类型
收费全文 | 14784篇 |
免费 | 925篇 |
国内免费 | 78篇 |
专业分类
耳鼻咽喉 | 205篇 |
儿科学 | 349篇 |
妇产科学 | 370篇 |
基础医学 | 2010篇 |
口腔科学 | 279篇 |
临床医学 | 1116篇 |
内科学 | 3889篇 |
皮肤病学 | 428篇 |
神经病学 | 1175篇 |
特种医学 | 382篇 |
外科学 | 2252篇 |
综合类 | 83篇 |
一般理论 | 6篇 |
预防医学 | 1155篇 |
眼科学 | 197篇 |
药学 | 860篇 |
中国医学 | 73篇 |
肿瘤学 | 958篇 |
出版年
2023年 | 85篇 |
2022年 | 188篇 |
2021年 | 396篇 |
2020年 | 190篇 |
2019年 | 332篇 |
2018年 | 409篇 |
2017年 | 296篇 |
2016年 | 306篇 |
2015年 | 344篇 |
2014年 | 506篇 |
2013年 | 653篇 |
2012年 | 997篇 |
2011年 | 1090篇 |
2010年 | 594篇 |
2009年 | 598篇 |
2008年 | 1021篇 |
2007年 | 1031篇 |
2006年 | 1013篇 |
2005年 | 993篇 |
2004年 | 846篇 |
2003年 | 805篇 |
2002年 | 710篇 |
2001年 | 214篇 |
2000年 | 246篇 |
1999年 | 251篇 |
1998年 | 117篇 |
1997年 | 122篇 |
1996年 | 83篇 |
1995年 | 68篇 |
1994年 | 61篇 |
1993年 | 66篇 |
1992年 | 118篇 |
1991年 | 101篇 |
1990年 | 117篇 |
1989年 | 101篇 |
1988年 | 69篇 |
1987年 | 69篇 |
1986年 | 69篇 |
1985年 | 81篇 |
1984年 | 49篇 |
1983年 | 40篇 |
1982年 | 26篇 |
1981年 | 25篇 |
1980年 | 26篇 |
1979年 | 19篇 |
1978年 | 20篇 |
1977年 | 19篇 |
1976年 | 21篇 |
1975年 | 24篇 |
1974年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
1.
2.
3.
4.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
5.
6.
Jenny U. Johansson Nathaniel S. Woodling Qian Wang Maharshi Panchal Xibin Liang Angel Trueba-Saiz Holden D. Brown Siddhita D. Mhatre Taylor Loui Katrin I. Andreasson 《The Journal of clinical investigation》2015,125(1):350-364
Microglia, the innate immune cells of the CNS, perform critical inflammatory and noninflammatory functions that maintain normal neural function. For example, microglia clear misfolded proteins, elaborate trophic factors, and regulate and terminate toxic inflammation. In Alzheimer’s disease (AD), however, beneficial microglial functions become impaired, accelerating synaptic and neuronal loss. Better understanding of the molecular mechanisms that contribute to microglial dysfunction is an important objective for identifying potential strategies to delay progression to AD. The inflammatory cyclooxygenase/prostaglandin E2 (COX/PGE2) pathway has been implicated in preclinical AD development, both in human epidemiology studies and in transgenic rodent models of AD. Here, we evaluated murine models that recapitulate microglial responses to Aβ peptides and determined that microglia-specific deletion of the gene encoding the PGE2 receptor EP2 restores microglial chemotaxis and Aβ clearance, suppresses toxic inflammation, increases cytoprotective insulin-like growth factor 1 (IGF1) signaling, and prevents synaptic injury and memory deficits. Our findings indicate that EP2 signaling suppresses beneficial microglia functions that falter during AD development and suggest that inhibition of the COX/PGE2/EP2 immune pathway has potential as a strategy to restore healthy microglial function and prevent progression to AD. 相似文献
7.
8.
9.
L.F. Mejía J.C. Gil M. Jaramillo 《Archivos de la Sociedad Espa?ola de Oftalmología》2019,94(7):331-336
ObjectiveTo propose the Intense Pulsed Light (IPL) therapy as a helpful supplementary treatment in patients with dry eye disease.Material and methodsRetrospective cross sectional design. Medical records of patients in whom dry eye disease symptoms were not satisfactorily controlled with medical therapy alone and who underwent additional IPL with at least three sessions completed. Data were analyzed before therapy and 3 weeks after its completion to asses improvement. Determination of symptoms, through a visual analog scale; tear film stability, through tear Break Up Time (tBUT); measurement of tear secretion, through Schirmer Test; and ocular surface staining with Van Bijsterveld score were evaluated. SPSS software and nonparametric analysis of repeated measures were used. The study was approved by the ethics committee.Results50 eyes from 25 subjects were reviewed. There were 9 males (36%) and 16 females (64%), with a median age of 59 years (IQR 52-64). The median of the symptoms scale was 8 (IQR 8-9) and 3 (IQR 2-4) before and after the therapy respectively (P < .05). The median of BUT was 4 (IQR 3-5) and 10 (IQR 8-11), Schirmer test was 13 (IQR 12-15) and 15 (IQR 13-20), and Van Bijsterveld score was 3 (RIC 3-4) and 2 (IQR 2-3) before and after the therapy respectively (P < .05, for all measurements).ConclusionIPL treatment has excellent results regarding both: dry eye disease symptoms improvement and in office objective tests such as tBUT, Schirmer test and Van Bijsterveld score; IPL could be considered as an effective adjunct for dry eye disease. 相似文献
10.